The CD11a binding site of efalizumab in psoriatic skin tissue as analyzed by Multi-Epitope Ligand Cartography robot technology. Introduction of a novel biological drug-binding biochip assay.
Bonnekoh, B
The CD11a binding site of efalizumab in psoriatic skin tissue as analyzed by Multi-Epitope Ligand Cartography robot technology. Introduction of a novel biological drug-binding biochip assay. [electronic resource] - Skin pharmacology and physiology 2007 - 96-111 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1660-5527
10.1159/000097982 doi
Adult
Aged
Antibodies, Monoclonal--metabolism
Antibodies, Monoclonal, Humanized
Binding Sites
CD11a Antigen--metabolism
Epitopes
Female
Fluorescein-5-isothiocyanate
Fluorescent Dyes
Humans
Immunologic Factors--metabolism
Male
Middle Aged
Models, Biological
Proteomics
Psoriasis--pathology
Robotics
Skin--metabolism
T-Lymphocytes--metabolism
The CD11a binding site of efalizumab in psoriatic skin tissue as analyzed by Multi-Epitope Ligand Cartography robot technology. Introduction of a novel biological drug-binding biochip assay. [electronic resource] - Skin pharmacology and physiology 2007 - 96-111 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1660-5527
10.1159/000097982 doi
Adult
Aged
Antibodies, Monoclonal--metabolism
Antibodies, Monoclonal, Humanized
Binding Sites
CD11a Antigen--metabolism
Epitopes
Female
Fluorescein-5-isothiocyanate
Fluorescent Dyes
Humans
Immunologic Factors--metabolism
Male
Middle Aged
Models, Biological
Proteomics
Psoriasis--pathology
Robotics
Skin--metabolism
T-Lymphocytes--metabolism